For purposes of this chapter the following definitions shall
apply:
(A) "Collaboration or
collaborating" means in the case of
an advanced
practice registered nurse designated as a certified nurse practitioner, a
clinical nurse specialist or a certified nurse-midwife, that a physician has
entered into a standard care arrangement with the nurse and is continuously
available to communicate with the nurse either in person, or by electronic
communication.
(B) "Consultation" means the
discussion or communication between a clinical nurse specialist, certified
nurse-midwife, or certified nurse practitioner with a physician prior to
initiating the prescription for a drug. The consultation relative to drug
therapy shall be documented in the patient's record and shall include the
consulting physician's name and the date the consultation took
place.
(C)(B) "Controlled
substance" means a drug, compound, mixture, preparation, or substance included
in schedule I, II, III, IV, or V pursuant to the provisions of Chapter 3719. of
the Revised Code.
(D)(C) "Contact hour"
means a minimum of sixty minutes of continuing education. For credit hours
earned on an academic quarter system, one credit hour is equivalent to ten
contact hours. For credit hours earned on an academic trimester system, one
credit hour is equivalent to twelve contact hours. For credit hours earned on
an academic semester system, one credit hour is equivalent to fifteen contact
hours.
(E)(D) "Course of study"
means an advanced level instructional program in pharmacology required by
section
4723.482 of the Revised Code for
advanced practice registered nursing licensure, that is either:
(1) Offered by an accredited educational
institution acceptable to the board. Accredited educational institutions
acceptable to the board include programs that are required to obtain approval,
authorization, or accreditation from one of the following:
(a) The chancellor of
higher educationOhio board of regents
under section 3333.07 of the Revised
Code;
(b) The Ohio department of
education under section
3313.90 of the Revised
Code;
(c) The Ohio state board of
career colleges and schools under section
3332.05 of the Revised
Code;
(d) The higher learning
commission of the north central association of colleges and schools;
(e) The accrediting council for independent
colleges and schools; or
(f) Any
other national or regional post-secondary education accreditation entity
recognized by the board; or
(2) A continuing education course that meets
the requirements of Chapter 4723-14 of the Administrative Code.
(F)(E) "Dangerous drug" has the same meaning as in section
4729.01 of the Revised
Code.
(G)(F) "Jurisdiction"
means any state, territory, or political subdivision of the United States in
which a board or legal approving authority regulates nurse licensure and
nursing practice and maintains membership in the national council of state
boards of nursing.
(H)(G) "Physician" means
an individual who holds a current valid license to practice medicine and
surgery, osteopathic medicine and surgery, or podiatric medicine and surgery
issued by the Ohio state medical board, or, in the case of applicants who hold
a current valid certificate of authority to prescribe drugs and therapeutic
devices from another jurisdiction, or who have been employed by the United
States government and authorized to prescribe in conjunction with that
employment, the physician's license may be issued by another jurisdiction as
defined in this chapter.
(I)
(H) "Sample drug" has
the same meaning as in section
2925.01 of the Revised
Code.
(J)
(I) "Types of drugs" means therapeutic drug
class.
Notes
Ohio Admin. Code
4723-9-01
Effective:
2/1/2021
Five Year Review (FYR) Dates:
10/15/2020 and
10/15/2025
Promulgated
Under: 119.03
Statutory
Authority: 4723.50
Rule
Amplifies: 4723.48,
4723.49,
4723.50
Prior
Effective Dates: 10/01/2001, 02/01/2002, 02/01/2006, 02/01/2011, 11/05/2012,
02/01/2016, 01/01/2018